Cancer is an illness that has affected many of us directly as well as indirectly. The illness itself can be found within the body in areas such as the lungs, liver, skin, and throat. There are various forms it also, but the fight against cancer has stepped it’s game up to another level by the introduction of Antibody Drug Conjugates. These advanced medications are far more advanced than treatments of the past. They fall under the “Antibody Based Therapy” sector of cancer research and they’ve been highly developed and tested for safe use. These therapies have the ability to spare non-targeted cells within the body while eradicating cancerous cells. This is innovation at it’s finest unlike Chemotherapy. Chemotherapy and others tend to affect all cells no matter the case. When this happens, extreme sickening of the patient will occur.
Dr. Clay Siegall and Seattle Genetics has transcended the game with their advanced (ADCETRIS) drug. ADCETRIS is one of the most successful medications on the market that has yielded some fine results. Dr. Siegall’s extensive knowledge comes from working in the industry for many years as well as having a strong passion for helpers others. He has a Ph.D in Genetics from George Washington University as well as a (BS) in Zoology from The University of Maryland. The guy just has what it takes to get things done, but did you know that Siegall is actually the company’s (CEO) and President? That’s right! He is also one of the co-founders that birthed this revolutionary institute. Seattle Genetics has the principles of:
Being such a well respected guy, Dr. Siegall is well accomplished as he holds up to 15 patents, has written over 70 publications, and is a guest speaker. The fight against this deadly disease is on and Dr. Clay Siegall is playing a crucial role in it’s demise.